More on vrtx
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $516.44 |
|
|||
| Open | $511.41 | ||||
| 52 Wk High | $134.71 | ||||
| 52 Wk Low | $73.31 | ||||
| Day High | $513.64 | ||||
| Day Low | $502.29 | ||||
| P/E | N/A | ||||
| EPS | $-1.98 | ||||
| Volume | 1,130,489 | ||||
- RBC Capital on Vertex (VRTX): 'SION Overhang Cleared; We Would Remain Buyers'
- Bernstein SocGen Reiterates Outperform Rating on Vertex (VRTX)
- Vertex Pharma (VRTX) Added to BofA US 1 List
- Vertex (VRTX) PT Raised to $562 at Wolfe Research
- Vertex stock jumps as rival cystic fibrosis drug fails trial
- BMO Capital Reiterates Outperform Rating on Vertex (VRTX) After Rival Fails
- Morgan Stanley tracks US drug market prescriptions for week ending July 31
- Vortex Energy Receives Final Technical Study Results for the Robinsons River Salt Project
- Vertex (VRTX) PT Raised to $617 at Barclays
- Form 10-Q VERTEX PHARMACEUTICALS For: Jun 30
Entities mentioned with VRTX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
